Akt inhibitors: mechanism of action and implications for anticancer therapeutics. - Wikidata - awgldk - TriplyDB

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

http://www.wikidata.org/entity/Q33641026

about

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling.Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.Effects of platycodin D on proliferation, apoptosis and PI3K/Akt signal pathway of human glioma U251 cells.Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway.Submicroscopic genomic rearrangements change gene expression in T-cell large granular lymphocyte leukemia.Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response.Functional role of AKT signaling in bovine early embryonic development: potential link to embryotrophic actions of follistatin.Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma.

P2860

Q35127769-3DFD76A4-B25A-4843-B324-DD51FCB53D5D Q36260672-C04B174D-FAC2-469A-AD6B-22A129EA790D Q38926252-BB919623-32B7-4733-A937-5943894D05C0 Q38984424-FCC1D3C8-41B2-48EF-9B36-1D2F10820E24 Q39013585-08700DC2-9DD9-4F39-8FAD-F4C3EA6A9876 Q47155414-36F28C52-4D34-458A-91E0-0A2468662665 Q47223756-3015D54D-C56A-4225-AEF9-DF87581650C2 Q53536514-0F4DBC2C-1719-4F09-9EF8-8AD7B56E63BB

P2860

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

http://www.wikidata.org/entity/Q33641026

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@ast

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@en

type

label

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@ast

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@en

prefLabel

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@ast

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@en

P1433

Q33641026-6E2160B8-CADF-4FDF-9EE1-EF0C7AF2EFF7

P1476

Q33641026-52DBEF14-F565-48A9-A3CC-886D453503A1

P2093

Q33641026-7F3AA26D-2D57-48CC-9D95-00D853F46275

Q33641026-7F901AA8-6B08-4C6F-973B-80BDC4B823CE

P2860

Q33641026-08545BC9-5101-4EF8-854A-EF9F5D492D85

Q33641026-0E91B6A6-3563-440A-A410-2AAEBBCAB13E

Q33641026-14601FB8-C786-4C18-981E-EC702E4D0367

Q33641026-32EB4235-F220-4EEA-891B-E3092AC08646

Q33641026-3FADDA8F-3297-445A-BBAB-49C66C9ADC5D

Q33641026-427639CD-A7CC-43DA-949D-D808676E4873

Q33641026-467053C4-89C9-4459-AE73-EABDB1B9E3C2

Q33641026-542F5572-E5A0-41E5-A971-82A1E93E7680

Q33641026-573D6B6D-7CD9-4310-86A0-7670DA083560

Q33641026-67419588-24FF-4F55-9A8B-61A4B43F23B2

P2888

Q33641026-AE1F9F75-5080-4F65-8B9C-D0C79320F071

P304

Q33641026-96FCDB4F-7339-437B-9F70-BC2A7E0B924C

P31

Q33641026-72CC69B8-FD45-4CB9-9040-5E2E24A7846B

P356

Q33641026-F5605294-BA5F-4FF2-A75B-65C10723BE81

P433

Q33641026-AA3021CD-A986-471C-B42A-D733525E9C80

P478

Q33641026-16D57D91-0073-4F62-BDBB-4C0E0CD215A5

P50

Q33641026-0552FCD9-B9FA-4910-A62C-5CD6AE9AD15F

P577

Q33641026-9C7B00A7-6E44-4D63-9F3A-67208D2C32E1

P5875

Q33641026-507457A0-C0D1-4634-A29B-DBCEB05A0DF6

P6179

Q33641026-7B242933-07FA-4184-89E2-5CBA639A5EA6

P698

Q33641026-548CBB61-0E17-4A49-A35A-DEA92BFF15F7

P932

Q33641026-2A853B7E-C993-427B-B8A0-38A6F00720C6

P356

P1433

Infectious Agents and Cancer

P1476

Akt inhibitors: mechanism of action and implications for anticancer therapeutics.

@en

P2093

Asfandyar Khan Niazi

http://www.w3.org/2001/XMLSchema#string

Jaikrit Bhutani

http://www.w3.org/2001/XMLSchema#string

P2860

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA

A mosaic activating mutation in AKT1 associated with the Proteus syndrome

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

AKT/PKB signaling: navigating downstream

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta

Akt1 in endothelial cell and angiogenesis

Physiological functions of protein kinase B/Akt

Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression

P2888

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-9378-8-49

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Asfandyar Sheikh

P577

2013-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259315771

http://www.w3.org/2001/XMLSchema#string

P6179

1016337361

http://www.w3.org/2001/XMLSchema#string

P698

24330834

http://www.w3.org/2001/XMLSchema#string

P932

4028840

http://www.w3.org/2001/XMLSchema#string